attention deficit hyperactivity disorder
GPTKB entity
Statements (55)
Predicate | Object |
---|---|
gptkbp:instanceOf |
neurological disorder
|
gptkbp:abbreviation |
ADHD
|
gptkbp:affects |
adults
children |
gptkbp:associatedWith |
gptkb:conduct_disorder
gptkb:oppositional_defiant_disorder substance use disorders sleep problems academic difficulties executive function deficits low self-esteem occupational difficulties relationship difficulties |
gptkbp:characterizedBy |
hyperactivity
impulsivity inattention |
gptkbp:comorbidity |
gptkb:depression
learning disabilities anxiety disorders |
gptkbp:controversy |
medication use
overdiagnosis |
gptkbp:diagnosedBy |
gptkb:DSM-5_criteria
clinical assessment |
gptkbp:DSM-5_code |
314.00
|
gptkbp:firstDescribed |
1902
|
gptkbp:gender |
more common in males
|
gptkbp:heritable |
yes
|
https://www.w3.org/2000/01/rdf-schema#label |
attention deficit hyperactivity disorder
|
gptkbp:ICD-10_code |
gptkb:F90
|
gptkbp:notableContributor |
gptkb:Sir_George_Frederic_Still
|
gptkbp:onset |
childhood
|
gptkbp:prevalence |
2.5% of adults worldwide
5% of children worldwide |
gptkbp:riskFactor |
genetics
premature birth prenatal exposure to tobacco |
gptkbp:subspecies |
combined presentation
predominantly hyperactive-impulsive predominantly inattentive |
gptkbp:symptom |
forgetfulness
difficulty organizing tasks difficulty sustaining attention difficulty waiting turn excessive talking fidgeting interrupting others |
gptkbp:treatment |
behavioral therapy
non-stimulant medication parent training psychoeducation school interventions stimulant medication |
gptkbp:bfsParent |
gptkb:Central_auditory_processing_disorder
gptkb:Ritalin |
gptkbp:bfsLayer |
5
|